Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03ZYZ
|
|||
| Former ID |
DIB013056
|
|||
| Drug Name |
Prophylactic dengue fever vaccine
|
|||
| Synonyms |
Attenuated tetravalent prophylactic dengue vaccine, GlaxoSmithKline; Prophylactic dengue fever vaccine, GlaxoSmithKline; T-DEN
Click to Show/Hide
|
|||
| Indication | Flavivirus infection [ICD-11: 1C80] | Phase 2 | [1] | |
| Company |
Walter Reed Army Institute of Research
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00370682) A Phase II Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy Adults in Thailand. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.